Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung; Disease, Interstitial, With Fibrosis”

483 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 483 results

Not applicableLooking for participantsNCT05310669
What this trial is testing

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 100
Not applicableEnded earlyNCT05267418
What this trial is testing

Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance

Who this might be right for
DyspneaLung DiseasesPulmonary Hypertension+3 more
Laval University 30
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Testing effectiveness (Phase 2)UnknownNCT02809456
What this trial is testing

Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients

Who this might be right for
Radiation Pneumonitis
Taipei Medical University WanFang Hospital 50
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)UnknownNCT05118256
What this trial is testing

Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis

Who this might be right for
SilicosisProgressive Massive FibrosisComplicated Silicosis
Instituto de investigación e innovación biomédica de Cádiz 18
Testing effectiveness (Phase 2)Study completedNCT06241560
What this trial is testing

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 20
Not applicableStudy completedNCT03411876
What this trial is testing

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Klaus Kenn 22
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Testing effectiveness (Phase 2)Study completedNCT05964335
What this trial is testing

Cough Reduction in IPF With Nalbuphine ER

Who this might be right for
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics 165
Post-approval studies (Phase 4)Study completedNCT00188955
What this trial is testing

Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Manitoba 40
Not applicableStudy completedNCT03567785
What this trial is testing

Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
KU Leuven 66
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Early research (Phase 1)Study completedNCT06589219
What this trial is testing

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibroses, Idiopathic
Calibr, a division of Scripps Research 89
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)WithdrawnNCT02603068
What this trial is testing

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary HypertensionPulmonary Fibrosis
United Therapeutics
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Not applicableStudy completedNCT07178197
What this trial is testing

Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Sarcopenia
Mersin University 60
Post-approval studies (Phase 4)Study completedNCT02788474
What this trial is testing

Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 347
Next Page